03-10-2025, 02:47 PM
July, 24th 5677
![[Image: QZFWWUv.png]](https://i.imgur.com/QZFWWUv.png)
Here in Zardugal, the brand name of the skrubaglutide preparation has been on everyone's lips for a long time, but elsewhere too, there is now growing interest in this apparent ‘miracle injection’. This was triggered by the positive evaluation and official approval of the drug for the treatment of morbid obesity and for the general prevention of further metabolic diseases in patients who are already obese
People in countries such as the Triad Republics, Egelion and Luthori, who are more affected by such ‘luxury diseases’ due to the economic conditions, the prevailing food supply and dietary habits, have shown particular interest in therapy with the novel drug.
In close consultation with the Economic Commissariat, FARMAKON-Z has now announced that it will ramp up production to manufacture batches intended exclusively for export. This is to ensure that international trade in the coveted drug does not lead to shortages at home.
According to the commissariat's press spokesman, this would be a ‘unique opportunity to obtain large amounts of foreign currency necessary for imports without creating a disadvantage for Zards affected by diabetes’.
For the future, substances with the same effect that can be administered orally are already being tested with promising results. However, it is still too early to make any definitive statements about the date of a possible market approval, according to Tristan Turnupilo, spokesperson for the research department at FARMAKON-Z.
![[Image: QZFWWUv.png]](https://i.imgur.com/QZFWWUv.png)
FARMAKON-Z LAUNCHES FANDIGRASON™ FOR INTERNATIONAL MARKET
Above all, the new area of application promises high sales
![[Image: ozempic-rathenow-100-1920x1080.jpg]](https://bilder.deutschlandfunk.de/29/19/a2/b7/2919a2b7-adb4-437b-bb6c-9cd007bc5732/ozempic-rathenow-100-1920x1080.jpg)
So far, the substances still have to be injected, but work is already underway to change this
Here in Zardugal, the brand name of the skrubaglutide preparation has been on everyone's lips for a long time, but elsewhere too, there is now growing interest in this apparent ‘miracle injection’. This was triggered by the positive evaluation and official approval of the drug for the treatment of morbid obesity and for the general prevention of further metabolic diseases in patients who are already obese
People in countries such as the Triad Republics, Egelion and Luthori, who are more affected by such ‘luxury diseases’ due to the economic conditions, the prevailing food supply and dietary habits, have shown particular interest in therapy with the novel drug.
In close consultation with the Economic Commissariat, FARMAKON-Z has now announced that it will ramp up production to manufacture batches intended exclusively for export. This is to ensure that international trade in the coveted drug does not lead to shortages at home.
According to the commissariat's press spokesman, this would be a ‘unique opportunity to obtain large amounts of foreign currency necessary for imports without creating a disadvantage for Zards affected by diabetes’.
For the future, substances with the same effect that can be administered orally are already being tested with promising results. However, it is still too early to make any definitive statements about the date of a possible market approval, according to Tristan Turnupilo, spokesperson for the research department at FARMAKON-Z.
Stinky Zard and Cryptothallerist
